CVS HEALTH Corp

CVS · CIK 0000064803

19 fiscal years · 70 SEC filings · every number carries its receipt

Revenue (FY)

$402.07B7.8%

FY2025

Net income (FY)

$1.77B61.7%

FY2025

Free cash flow (FY)

$7.81B23.4%

FY2025

Diluted EPS (FY)

$1.3962.0%

FY2025

The story, charted

The shape of the business

FY2007–FY2025 · hover any year for its receipt

Revenue & net incomeRevenueNet income

revenue 5.3× since FY2007 · net margin 3.5% → 0.4%

MarginsNet marginFCF margin

FY2025: net 0.4% · free cash flow 1.9% of revenue

Cash engineOperating cash flowFree cash flow

FY2025: $10.64B operating cash − $2.83B capex = $7.81B free cash flow

Returns on capitalReturn on equityReturn on assets

return on equity 9% (FY2008) → 2% (FY2025) · on assets 0.7%

Balance sheetLiabilitiesEquity

FY2025: $253.54B assets · $178.16B liabilities · $75.21B equity

The receipts

Financial statements

Annual Quarterly (as reported)

USD in millions except per-share and share counts. Every value links to the filing it came from — hover for the us-gaap tag, click for the 10-K/10-Q on sec.gov.

USD millions	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Revenue	402,067	372,809	357,776	322,467	292,111	268,706	256,776	193,919	184,765	177,526	153,290	139,367
Net income	1,768	4,614	8,344	4,311	8,001	7,179	6,634	(594)	6,622	5,317	5,237	4,644
Diluted EPS	1.39	3.66	6.47	3.26	6.02	5.46	5.08	(0.57)	6.44	4.90	4.63	3.96
Diluted shares	1,271	1,262	1,290	1,323	1,329	1,314	1,305	1,044	1,024	1,079	1,126	1,169
Operating cash flow	10,639	9,107	13,426	16,177	18,265	15,865	12,848	8,865	8,007	10,141	8,539	8,137
Capital expenditures	2,832	2,781	3,031	2,727	2,520	2,437	2,457	2,037	1,918	2,224	2,367	2,136
Free cash flow	7,807	6,326	10,395	13,450	15,745	13,428	10,391	6,828	6,089	7,917	6,172	6,001
Cash & equivalents	8,453	8,586	8,196	12,945	9,408	7,854	5,683	4,059	1,696	3,371	2,459	2,481
Total assets	253,538	253,215	249,728	228,275	232,999	230,715	222,449	216,668	95,131	94,462	92,437	74,187
Total liabilities	178,156	177,485	173,092	156,506	157,618	161,014	158,279	157,947	57,436	—	—	—
Shareholders' equity	75,214	75,560	76,461	71,469	75,075	69,389	63,864	58,403	37,691	36,830	37,196	37,958

Figures as reported in SEC filings, normalized by stonks with the tag mapping shown on hover; missing tags render as “—”, never as zero. Free cash flow is derived (operating cash flow − capex) with both parents recorded in its lineage. See methodology.